Henry Ford Health System – Rheumatology
Primary Coordinator: Jenna Hudy 313-916-9328
- Indication: Vasculitis
- Enrollment Status: Open
- Protocol: 20220159
- Drug: Avacopan
- Sponsor: Amgen
- Description: A randomized, double-blind, placebo-controlled phase 4 clinical trial to evaluate the long-term safety and efficacy of Avacopan in subjects with Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
